Effects of Davunetide on N-acetylaspartate and Choline in Dorsolateral Prefrontal Cortex in Patients with Schizophrenia

Understanding aberrant white matter development in schizophrenia: an avenue for therapy?

(2011) Mark Walterfang et al.   Expert Review of Neurotherapeutics

Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia

(2011) Daniel C. Javitt et al.   SCHIZOPHRENIA RESEARCH

Proton Magnetic Resonance Spectroscopy and Illness Stage in Schizophrenia—A Systematic Review and Meta-Analysis

(2010) Stefan Brugger et al.   BIOLOGICAL PSYCHIATRY

NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse—A microtubule-deficient model of schizophrenia

(2010) Avia Merenlender-Wagner et al.   PEPTIDES

Microtubules, schizophrenia and cognitive behavior: Preclinical development of davunetide (NAP) as a peptide-drug candidate

(2010) Illana Gozes   PEPTIDES

The effect of clozapine on regional cerebral blood flow and brain metabolite ratios in schizophrenia: Relationship with treatment response

(2009) Aygun Ertugrul et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Proton Magnetic Resonance Spectroscopy in Multiple Sclerosis

(2008) Balasrinivasa R. Sajja et al.   NEUROIMAGING CLINICS OF NORTH AMERICA

Progressive Brain Volume Loss in Schizophrenia Over the Course of the Illness: Evidence of Maturational Abnormalities in Early Adulthood

(2007) Neeltje E.M. van Haren et al.   BIOLOGICAL PSYCHIATRY